Finally, their study suggested that a combination of IR (5 Gy) and quercetin (20 mM) could be a novel therapeutic approach in colon cancer by suppressing the Notch-1 signaling pathway in CSCs. Here, NOTCH1 is linked to malignant colon neoplasm.